A Case Analysis

2002;121;1337-1342 Chest Franklin G. Miller and Andrew F. Shorr : A Case Analysis * Clinical Trials Ethical Assessment of Industry-Sponsored http://chestjournal.org/cgi/content/abstract/121/4/1337 services can be found online on the World Wide Web at: The online version of this article, along with updated information and ). ISSN: 0012-3692. http://www.chestjournal.org/misc/reprints.shtml ( copyright holder reproduced or distributed without the prior written permission of the 60062. All rights reserved. No part of this article or PDF may be American College of Chest Physicians, 3300 Dundee Road, Northbrook IL It has been published monthly since 1935. Copyright 2007 by the CHEST is the official journal of the American College of Chest Physicians.

[1]  T. Bodenheimer,et al.  Uneasy alliance--clinical investigators and the pharmaceutical industry. , 2000, The New England journal of medicine.

[2]  K. Nolop,et al.  Once-daily mometasone furoate dry powder inhaler in the treatment of patients with persistent asthma. , 2000, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[3]  R. Jaffe.  A National Survey of Policies on Disclosure of Conflicts of Interest in Biomedical Research , 2001 .

[4]  S. Ellenberg,et al.  Placebo-Controlled Trials and Active-Control Trials in the Evaluation of New Treatments. Part 2: Practical Issues and Specific Cases , 2000, Annals of Internal Medicine.

[5]  T. Haahtela,et al.  Dose-ranging study of mometasone furoate dry powder inhaler in the treatment of moderate persistent asthma using fluticasone propionate as an active comparator. , 2001, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[6]  G. Settipane,et al.  Dose-ranging study of a new steroid for asthma: mometasone furoate dry powder inhaler. , 1999, Respiratory medicine.

[7]  F. Miller,et al.  Advertising for clinical research. , 1999, IRB.

[8]  M. Kavuru,et al.  Salmeterol and fluticasone propionate combined in a new powder inhalation device for the treatment of asthma: a randomized, double-blind, placebo-controlled trial. , 2000, The Journal of allergy and clinical immunology.

[9]  R. A. McIvor,et al.  The Placebo Effect in Asthma Drug Therapy Trials: A Meta-Analysis , 2000, The Journal of asthma : official journal of the Association for the Care of Asthma.

[10]  Gina Kolata,et al.  Drug trials hide conflicts for doctors. , 1999, The New York times on the Web.

[11]  R. Rettig.  The industrialization of clinical research. , 2000, Health affairs.

[12]  T. Lemmens,et al.  Ethics Review for Sale? Conflict of Interest and Commercial Research Review Boards , 2000, The Milbank quarterly.

[13]  C B Anderson,et al.  A national survey of policies on disclosure of conflicts of interest in biomedical research. , 2000, The New England journal of medicine.

[14]  C. Grady,et al.  What makes clinical research ethical? , 2000, JAMA.

[15]  A. Leon.  Can placebo controls reduce the number of nonresponders in clinical trials? A power-analytic perspective. , 2001, Clinical therapeutics.

[16]  D. Stempel.  Montelukast added to inhaled beclomethasone in treatment of asthma. , 2000, American journal of respiratory and critical care medicine.

[17]  R. Zuwallack,et al.  Long-term efficacy and safety of fluticasone propionate powder administered once or twice daily via inhaler to patients with moderate asthma. , 2000, Chest.

[18]  S S Ellenberg,et al.  Placebo-Controlled Trials and Active-Control Trials in the Evaluation of New Treatments. Part 1: Ethical and Scientific Issues , 2000, Annals of Internal Medicine.

[19]  T. Ahmed,et al.  Mometasone furoate: efficacy and safety in moderate asthma compared with beclomethasone dipropionate. , 2001, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[20]  P. Barnes,et al.  Efficacy of inhaled corticosteroids in asthma. , 1998, The Journal of allergy and clinical immunology.